Mythic Therapeutics

company

About

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$103M
Industries
Biotechnology,Health Care,Life Science,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$103M
Mythic Therapeutics has raised a total of $103M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 15, 2021 Series B $103M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Mythic Therapeutics is funded by 1 investors. Highside Capital Management are the most recent investors.
Investor Name Lead Investor Funding Round
Highside Capital Management Series B